Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir.

Antimicrobial agents and chemotherapy - 1 Nov 2015

Schnell Gretja, Tripathi Rakesh, Beyer Jill, Reisch Thomas, Krishnan Preethi, Lu Liangjun, Dekhtyar Tatyana, Hall Coleen, Vilchez Regis A, Pilot-Matias Tami, Collins Christine

Abstract excerpt

Hepatitis C virus (HCV) genotype 4 (GT4) is genetically diverse, with 17 confirmed subtypes, and comprises approximately 13% of infections worldwide. In this study, we identified GT4 subtypes by phylogenetic analysis, assessed differences in patient demographics across GT4 subtypes, examined baseline sequence variability among subtypes and the potential impact on treatment outcome, and analyzed the development of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anilides
Share to Carbamates

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclopropanes

Share to Lactams, Macrocyclic

Share to Macrocyclic Compounds

Share to Ritonavir

Share to Sulfonamides

Share to Valine

Source

Open in PubMed Open full text

Identifiers

PMID: 26282418
DOI: 10.1128/AAC.01229-15
PMCID: PMC4604390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir.PMID 26282418Read ↗

Characterization of demographics and NS5A genetic diversity for hepatitis C virus genotype 4-infected patients with or without cirrhosis treated with ombitasvir/paritaprevir/ritonavir.Semantic proximity Read ↗

Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir.Semantic proximity Read ↗

Hepatitis C virus genotype 4: A poorly characterized endemic genotype.Semantic proximity Read ↗

NS5A Sequence Heterogeneity and Mechanisms of Daclatasvir Resistance in Hepatitis C Virus Genotype 4 Infection.Semantic proximity Read ↗

Hepatitis C genotype 4: A report on resistance-associated substitutions in NS3, NS5A, and NS5B genes.Semantic proximity Read ↗

Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4.Semantic proximity Read ↗

Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection.Semantic proximity Read ↗

Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial.Semantic proximity Read ↗

Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian PatientsSemantic proximity Read ↗

Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses.Semantic proximity Read ↗

Hepatitis C genotype 4Semantic proximity Read ↗

Determinants of Infection Outcome in HCV-Genotype 4.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.